- Stocks /
- NIB Holdings Ltd (ASX: NHF) /
NIB Holdings Ltd (ASX: NHF) Share Price and News
Price
$7.53
Movement
0.05 (+0.67%)
As at 19 Sep 3:09pm (20 mins delayed)
52 Week Range
$5.36 - $8.26
1 Year Return
+31.64%
NIB Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Earnings Yield
5.27%
Franking
100%
Dividend per share
0.29
Year To Date Return
43.61%
Shares Outstanding
487.02 million
Earnings per share
0.400
Share Price
$7.53
Day Change
0.05 (+0.67%)
52 Week Range
$5.36 - $8.26
Yesterday's Close
$7.48
Today's Open
$7.52
Days Range
$7.50 - $7.565
Volume
381,201
Avg. Volume (1 month)
996,864
Turnover
$2,871,013
As at 19 Sep 3:09pm
NIB Holdings Ltd (ASX: NHF)
Latest News

Healthcare Shares
Overinvested in CSL? Here are two alternative ASX healthcare stocks
| Tristan Harrison

Broker Notes
Analysts say these ASX 300 shares are buys with 14% to 25% upside
| James Mickleboro

Share Market News
5 things to watch on the ASX 200 on Friday
| James Mickleboro

Share Gainers
Here are the top 10 ASX 200 shares today
| Sebastian Bowen

Healthcare Shares
Is this beaten-down ASX healthcare share a bargain buy now?
| Tristan Harrison

Broker Notes
Don't miss these changes to broker ratings on ASX shares
| Zach Bristow

Financial Shares
Why did the NIB share price just hit a 3-year low?
| Bronwyn Allen

Healthcare Shares
Down 20%, is the NIB share price undervalued?
| James Mickleboro

Financial Shares
Down 21% this year, are NIB shares a buy?
| Zach Bristow

Dividend Investing
How I'd build an ASX passive income portfolio with $10k
| James Mickleboro

Healthcare Shares
Here's why ASX 200 health insurance shares like Medibank are being trounced today
| Tristan Harrison

Cheap Shares
History says these 3 ASX shares are dirt cheap today
| Mitchell Lawler
Frequently Asked Questions
-
The company was established as Newcastle Industrial Benefits (NIB) Hospital Fund in 1952 to provide health insurance for workers at BHP Steelworks, Mayfield. It changed its name to NIB Health Funds Ltd in 1966.
In 2007 members voted in favour of demutualising the health fund, and in November that year, NIB became the first Australian private health insurer to list on the ASX.
-
NIB pays a fully franked dividend in April and October.
Dividend Payment History Data provided by Morningstar.
Ex-Date | Amount | Franking | Type | Payable |
---|---|---|---|---|
04 Sep 2025 | $0.1600 | 100.00% | Final | 07 Oct 2025 |
06 Mar 2025 | $0.1300 | 100.00% | Interim | 09 Apr 2025 |
05 Sep 2024 | $0.1400 | 100.00% | Final | 08 Oct 2024 |
07 Mar 2024 | $0.1500 | 100.00% | Interim | 10 Apr 2024 |
04 Sep 2023 | $0.1500 | 100.00% | Final | 03 Oct 2023 |
02 Mar 2023 | $0.1300 | 100.00% | Interim | 03 Apr 2023 |
05 Sep 2022 | $0.1100 | 100.00% | Final | 04 Oct 2022 |
03 Mar 2022 | $0.1100 | 100.00% | Interim | 04 Apr 2022 |
02 Sep 2021 | $0.1400 | 100.00% | Final | 05 Oct 2021 |
04 Mar 2021 | $0.1000 | 100.00% | Interim | 06 Apr 2021 |
03 Sep 2020 | $0.0400 | 100.00% | Final | 06 Oct 2020 |
05 Mar 2020 | $0.1000 | 100.00% | Interim | 07 Apr 2020 |
02 Sep 2019 | $0.1300 | 100.00% | Final | 30 Sep 2019 |
06 Sep 2018 | $0.1100 | 100.00% | Final | 05 Oct 2018 |
01 Mar 2018 | $0.0900 | 100.00% | Interim | 03 Apr 2018 |
07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
02 Mar 2017 | $0.0850 | 100.00% | Interim | 03 Apr 2017 |
08 Sep 2016 | $0.0900 | 100.00% | Final | 07 Oct 2016 |
02 Mar 2016 | $0.0575 | 100.00% | Interim | 01 Apr 2016 |
10 Sep 2014 | $0.0900 | 100.00% | Special Cash | 03 Oct 2014 |
10 Sep 2014 | $0.0575 | 100.00% | Final | 03 Oct 2014 |
05 Sep 2013 | $0.0500 | 100.00% | Final | 04 Oct 2013 |
04 Mar 2013 | $0.0500 | 100.00% | Interim | 05 Apr 2013 |
05 Mar 2012 | $0.0425 | 100.00% | Interim | 05 Apr 2012 |
07 Mar 2011 | $0.0400 | 100.00% | Interim | 08 Apr 2011 |
05 Mar 2010 | $0.0200 | 100.00% | Interim | 08 Apr 2010 |
14 Sep 2009 | $0.0440 | 100.00% | Final | 09 Oct 2009 |
NHF ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
8th Sep 2025 2025-09-08T15:25:48 | Change of Director's Interest Notice | YesNo | 3:25pm | 3 | 190k |
5th Sep 2025 2025-09-05T17:06:58 | Ceasing to be a substantial holder from MUFG | YesNo | 5:06pm | 73 | 1.2M |
5th Sep 2025 2025-09-05T14:02:58 | Notification of cessation of securities - NHF | YesNo | 2:02pm | 4 | 13k |
5th Sep 2025 2025-09-05T14:01:48 | Notification regarding unquoted securities - NHF | YesNo | 2:01pm | 6 | 16k |
5th Sep 2025 2025-09-05T13:59:08 | Change of Director's Interest Notice | YesNo | 1:59pm | 6 | 292k |
4th Sep 2025 2025-09-04T18:53:22 | Ceasing to be a substantial holder | YesNo | 6:53pm | 3 | 618k |
26th Aug 2025 2025-08-26T16:42:14 | Becoming a substantial holder from MUFG | YesNo | 4:42pm | 275 | 2.5M |
25th Aug 2025 2025-08-25T16:38:15 | Becoming a substantial holder | YesNo | 4:38pm | 9 | 724k |
25th Aug 2025 2025-08-25T08:11:16 | 2025 Group Climate-Related Disclosure | YesNo | 8:11am | 17 | 1.6M |
25th Aug 2025 2025-08-25T08:11:11 | 2025 Sustainability Report | YesNo | 8:11am | 53 | 8.4M |
About NIB Holdings Ltd
NIB Holdings Limited (ASX: NHF) provides health and medical insurance to more than 1.5 million Australian and New Zealand residents.
In addition, it covers more than 180,000 international students and workers in Australia.
The company also offers travel insurance through its NIB Travel business, and provides health insurance plans to corporate groups through its GU Health business.
NHF Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
17 Sep 2025 | $7.57 | $-0.01 | -0.13% | 804,445 | $7.54 | $7.60 | $7.51 |
16 Sep 2025 | $7.58 | $-0.01 | -0.13% | 378,701 | $7.60 | $7.63 | $7.50 |
15 Sep 2025 | $7.59 | $0.06 | 0.80% | 929,895 | $7.53 | $7.60 | $7.47 |
12 Sep 2025 | $7.53 | $0.07 | 0.94% | 557,114 | $7.50 | $7.57 | $7.47 |
11 Sep 2025 | $7.46 | $0.02 | 0.27% | 521,835 | $7.43 | $7.50 | $7.36 |
10 Sep 2025 | $7.44 | $0.13 | 1.78% | 851,707 | $7.31 | $7.44 | $7.29 |
09 Sep 2025 | $7.31 | $0.00 | 0.00% | 571,508 | $7.31 | $7.33 | $7.29 |
08 Sep 2025 | $7.31 | $-0.06 | -0.81% | 738,664 | $7.30 | $7.35 | $7.23 |
05 Sep 2025 | $7.37 | $0.04 | 0.55% | 1,160,363 | $7.40 | $7.40 | $7.31 |
04 Sep 2025 | $7.33 | $-0.13 | -1.74% | 1,047,355 | $7.42 | $7.44 | $7.28 |
03 Sep 2025 | $7.46 | $-0.08 | -1.06% | 816,293 | $7.49 | $7.54 | $7.42 |
02 Sep 2025 | $7.54 | $-0.09 | -1.18% | 789,231 | $7.58 | $7.61 | $7.50 |
01 Sep 2025 | $7.63 | $-0.05 | -0.65% | 892,037 | $7.63 | $7.73 | $7.58 |
29 Aug 2025 | $7.68 | $0.22 | 2.95% | 2,150,708 | $7.46 | $7.75 | $7.40 |
28 Aug 2025 | $7.46 | $-0.08 | -1.06% | 783,717 | $7.55 | $7.70 | $7.37 |
27 Aug 2025 | $7.54 | $-0.02 | -0.26% | 837,950 | $7.62 | $7.88 | $7.48 |
26 Aug 2025 | $7.56 | $-0.36 | -4.55% | 2,081,304 | $7.89 | $7.98 | $7.54 |
25 Aug 2025 | $7.92 | $0.21 | 2.72% | 1,796,069 | $7.92 | $8.26 | $7.83 |
22 Aug 2025 | $7.71 | $0.01 | 0.13% | 739,140 | $7.70 | $7.74 | $7.65 |
21 Aug 2025 | $7.70 | $0.13 | 1.72% | 910,481 | $7.63 | $7.77 | $7.62 |
20 Aug 2025 | $7.57 | $0.05 | 0.66% | 2,194,989 | $7.55 | $7.63 | $7.53 |
19 Aug 2025 | $7.52 | $-0.08 | -1.05% | 789,809 | $7.58 | $7.61 | $7.51 |
Director Transactions Data provided by Morningstar.
Date | Director | Type | Amount | Value | Notes |
---|---|---|---|---|---|
04 Sep 2025 | Jill Watts | Buy | 2,013 | $14,936 |
On-market trade.
|
02 Sep 2025 | Jill Watts | Buy | 4,660 | $34,996 |
On-market trade.
|
01 Sep 2025 | Edward Close | Exercise | 46,681 | $356,176 |
Conversion of securities. 253,206 Rights
|
01 Sep 2025 | Edward Close | Issued | 37,451 | $285,751 |
Conversion of securities.
|
01 Sep 2025 | Edward Close | Issued | 42,722 | $325,968 |
Conversion of securities.
|
07 May 2025 | Edward Close | Sell | 32,000 | $220,145 |
On-market trade.
|
06 Dec 2024 | Edward Close | Issued | 154,359 | $865,953 |
Issue of securities. 299,887 Rights
|
22 Nov 2024 | Jill Watts | Buy | 3,597 | $19,999 |
On-market trade.
|
21 Nov 2024 | Peter Harmer | Buy | 17,574 | $100,149 |
On-market trade.
|
18 Nov 2024 | Mark Fitzgibbon | Sell | 35,000 | $201,202 |
On-market trade.
|
15 Nov 2024 | Mark Fitzgibbon | Sell | 35,000 | $203,000 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr David L Gordon | Non-Executive DirectorNon-Executive Chairman | May 2020 |
Mr Gordon has over 30 years of experience as a director of both public and private companies and in corporate advisory roles to Australian and international organizations. He brings knowledge of strategy development, mergers and acquisitions, as well as capital raisings, IPOs and joint ventures. David has held several senior roles with Freehills (now Herbert Smith Freehills Kramer) (Partner) and boutique investment bank Wentworth Associates. In addition, he founded an independent corporate advisory and investment firm, Lexicon Partners, in 2001.
|
Ms Anne Joan Loveridge | Non-Executive Director | Feb 2017 |
Ms Loveridge has more than 35 years of experience in the highly regulated financial services sector, including health insurance. She has knowledge of financial and regulatory reporting, risk management and compliance frameworks. She has been a Non-Executive Director for ASX-listed entities in the financial services sector for more than nine years. She is a member of the Risk and Reputation Committee
|
Mr Donal Paul O'Dwyer | Non-Executive Director | Mar 2016 |
Mr O'Dwyer has knowledge of the health industry globally, after more than 35 years in senior executive and Non-Executive Director roles within the healthcare products and medical device sectors. He has experience in business, science, engineering, manufacturing and management. During his tenure with Baxter Healthcare, he rose through the ranks from plant manager to President of the Cardiovascular Group Europe, having an understanding of the inner workings of business strategy and fiscal management, from the floor of the factory through to the boardroom. He then worked for Cordis (the cardiovascular device franchise of Johnson & Johnson) - initially as European President and later, when he located to the US, he served as Worldwide President. He is a member of the People Committee.
|
Mr Peter Harmer | Non-Executive Director | Jul 2021 |
Mr Harmer has over 40 years of experience in the Australian and international insurance and financial sectors, including over 30 years in a senior executive capacity. He has an understanding of the global insurance and reinsurance markets and has driven the improvement of business and customer experiences through digital innovation. During his career, Peter accelerated digital engagement through re-examining customer journeys to understand pain points and introduced the right tools and technology to help improve the overall customer experience. Peter was formerly Chief Executive Officer of Insurance Australia Group (IAG), CGU Insurance, Aon Limited UK, Aon Risk Services Australia Pacific and Aon Re Australia and has led business growth agendas, major acquisitions, and industry roll-ups. He is the Chair of the Risk and Reputation Committee and a member of the People Committee.
|
Ms Jacqueline Chow | Non-Executive Director | Apr 2018 |
Mr Chow has more than 20 years of experience working with global blue-chip consumer product multinationals in a range of executive and non-executive positions in general management, strategy, marketing as well as technology and innovation. Her early career concentrated on business analytics, brand equity and marketing. She has also led company-wide business transformation by driving productivity. She is Chair of the People Committee.
|
Mr Brad Welsh | Non-Executive Director | Jul 2023 |
Mr Welsh has spent more than a decade advising global resource companies, including Energy Resources of Australia and Rio Tinto, bringing both public sector and commercial skills to his role. Through his senior leadership roles in mining and energy, Brad has focused on operational efficiency, safety and building trust with stakeholders, including traditional landowners. Through media and senior advisory roles in the Office of the NSW Premier, the Minister for Planning, and the Prime Minister of Australia, he has acquired an understanding of the public sector. He is a member of the Risk and Reputation Committee and the People Committee.
|
Ms Jill Watts | Non-Executive Director | Jul 2023 |
Ms Watts has more than 40 years of experience leading global businesses. She has worked across the private sector, with governments affecting public policy change, and private research institutes. She has experience working with companies with operations in Australia, the UK, France, and South Africa. Prior to returning to Australia in 2017, Jill was the Group CEO of the UK's private hospital group, BMI Healthcare, responsible for 60 facilities across the UK. Jill was also Group CEO of Ramsay Healthcare, UK. She has joined the Boards of global companies since returning to Australia. She is a member of the Risk and Reputation Committee.
|
Mr Edward Close | Chief Executive OfficerManaging Director | Dec 2024 |
Mr Close has experience in financial services and health insurance, having overseen P&L, distribution, customer, digital and marketing functions. Ed has previously held senior management roles at the Commonwealth Bank of Australia, where he worked across product management, strategy and customer engagement in the consumer banking division. He is a member of the Risk Committee.
|
Ms Roslyn Toms | Group Executive - Legal and Chief Risk OfficerCompany Secretary | Apr 2013 |
-
|
Mr Jordan French | Senior Corporate CounselJoint Company Secretary | Aug 2017 |
-
|
James Barr | Chief Executive - Australian Private Health Insurance |
-
|
|
Martin Adlington | Chief Executive - nib Thrive |
-
|
|
Rob Hennin | Chief Executive Officer - nib New Zealand |
-
|
|
Nick Freeman | Group Chief Financial Officer |
-
|
|
Brendan Mills | Group Chief Information Officer |
-
|
|
Lauren Daniels | Group Chief People Officer |
-
|
|
Roslyn Toms | Group Executive - Legal and Chief Risk OfficerCompany Secretary |
-
|
|
Matthew Neat | Group Executive - Strategy and Development |
-
|
|
Jordan French | Senior Corporate CounselJoint Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Hsbc Custody Nominees (Australia) Limited | 101,122,953 | 20.76% |
Citicorp Nominees Pty Limited | 56,960,720 | 11.70% |
J P Morgan Nominees Australia Pty Limited | 46,369,538 | 9.52% |
BNP Paribas Noms Pty Ltd | 10,665,898 | 2.19% |
BNP Paribas Nominees Pty Ltd <Agency Lending A/C> | 3,764,848 | 0.77% |
National Nominees Limited | 2,373,958 | 0.49% |
BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 2,054,537 | 0.42% |
HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> | 1,465,800 | 0.30% |
HSBC Custody Nominees (Australia) Limited i | 1,347,857 | 0.28% |
Netwealth Investments Limited <Wrap Services A/C> | 1,250,920 | 0.26% |
BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 1,183,793 | 0.24% |
First Samuel Ltd Acn 086243567 <Anf Its Mda Clients A/C> | 1,145,778 | 0.24% |
Cpu Share Plans Pty Ltd <Nhf Escrow Trust Master A/C> | 966,792 | 0.20% |
Ioof Investment Services Limited <Ips Superfund A/C> | 803,376 | 0.16% |
Citicorp Nominees Pty Limited <Colonial First State Inv A/C> | 755,044 | 0.16% |
BNP Paribas Nominees Pty Ltd <Agency Lending Collateral> | 703,400 | 0.14% |
Fitzy (Nsw) Pty Ltd <Fitz Family Fund A/C> | 546,621 | 0.11% |
Netwealth Investments Limited <Super Services A/C> | 522,187 | 0.11% |
BNP Paribas Noms (Nz) Ltd | 433,540 | 0.09% |
IOOF Investment Services Limited <IOOF IDPS A/C> | 424,466 | 0.08% |